Boston Scientific Medsurg — Goodwill increased by 0.3% to $7.71B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.0%, from $7.48B to $7.71B. Over 4 years (FY 2021 to FY 2025), Medsurg — Goodwill shows an upward trend with a 34.3% CAGR.
An increase suggests recent acquisitions, while a decrease may indicate impairment charges due to underperformance.
Represents the total carrying value of goodwill allocated to the MedSurg business segment. This asset arises from histor...
Commonly reported by medical device peers as part of segment-level asset disclosures.
bsx_segment_medsurg_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.06B | $2.63B | $2.60B | $4.24B | $4.24B | $4.23B | $4.24B | $4.24B | $4.61B | $4.61B | $5.35B | $5.34B | $5.34B | $5.35B | $7.48B | $7.50B | $7.53B | $7.69B | $7.71B |
| QoQ Change | — | +28.0% | -1.3% | +63.4% | -0.1% | -0.3% | +0.2% | +0.0% | +8.7% | +0.1% | +16.0% | -0.1% | -0.0% | +0.1% | +39.9% | +0.2% | +0.3% | +2.1% | +0.3% |
| YoY Change | — | — | — | — | +106.2% | +60.6% | +63.1% | -0.2% | +8.6% | +9.1% | +26.2% | +26.1% | +15.9% | +16.0% | +39.9% | +40.4% | +40.9% | +43.7% | +3.0% |